| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |